No Picture
San Francisco Biotech Jobs

QC Scientist, Technology – GENENTECH – Vacaville, CA

Owning, managing and implementation of methods for microbiology/adventitious agent testing (AAT) for the PT commercial QC network to establish/maintain an up-to…From Genentech – Thu, 07 Jan 2021 15:08:56 GMT – View all Vacaville, CA jobs […]

No Picture
San Francisco Biotech Jobs

Postdoctoral Fellow – Structural Biology, Wang and Ashkenazi Labs – GENENTECH – San Francisco, CA

(2014) Opposing unfolded-protein-response signals converge on death receptor 5 to control apoptosis. More information about the Genentech Postdoctoral Program:From Genentech – Thu, 07 Jan 2021 15:08:55 GMT – View all San Francisco, CA jobs […]

No Picture
News

Twist Bioscience Supplies Centers for Disease Control and Prevention with Custom SARS-CoV-2 Synthetic RNA Controls

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #COVID19–Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it will supply … […]

No Picture
News

ArsenalBio Announces Multi-Program Discovery Collaboration with Bristol Myers Squibb to Advance Next-Generation T cell Therapies for Solid Tumors

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–ArsenalBio announces multi-program discovery collaboration with Bristol Myers Squibb to advance next-generation T cell therapies for solid tumors. […]

No Picture
News

Gary Glick, Keith Flaherty now have $270M to realize their vision for Precision Oncology 2.0 — we’ll just have to wait for the details

Whatever investors have peeped about Gary Glick and Keith Flaherty’s game plan to bring about Precision Oncology 2.0, it’s good enough for a $162 million infusion into Scorpion Therapeutics just weeks after its $108 million Series A.
The announcement m… […]

No Picture
News

Bristol Myers Squibb ices licensing pact with ArsenalBio to draft its designer T cells into the solid tumor fight

Back in late 2019, South San Francisco’s ArsenalBio uncorked an $85 million round to kickstart its designer T cell project with some splashy backers on board. Since then, Arsenal went to work: tripling its team, workshopping its product strategy and — … […]